Clot-busting drug for stroke in people with active cancer
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a clot-busting drug given through a vein can safely and effectively treat strokes in people who also have active cancer. It aims to see if this treatment can improve recovery without increasing bleeding risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have had stroke symptoms within the last 24 hours, or woke up with stroke symptoms that started within 24 hours.
- You must have Active Cancer, meaning cancer diagnosed in the last 6 months, cancer that has come back, spread, or is being treated, or blood cancer that is not in remission.
- You must not be planning to have a procedure that removes the blood clot directly (endovascular treatment).
- You must be able to do most daily activities on your own before this stroke (score of 0, 1, or 2 on a standard scale).
- You must not have any bleeding in the brain, recent major bleeding, or high risk of bleeding, and you must not be on certain blood thinners unless approved by the doctor.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This study tests whether a clot-busting medicine given through a vein can help people who have had a stroke in the last 3 months and are now having another stroke. The goal is to see if this treatment is safe and improves recovery.
This trial tests whether giving a clot-busting medication (tenecteplase) before the standard clot-removal procedure (thrombectomy) helps patients with a large stroke more than just the procedure alone. If the treatment works, it could improve recovery and reduce disability after a severe stroke.
This trial tests whether a stronger clot-busting drug (tenecteplase) is safe and works for people who have had a stroke while taking a common blood thinner. If you qualify, you may get this treatment within a few hours of your stroke to help improve recovery.
This trial tests a medication called tirofiban given intravenously after standard thrombolysis to see if it improves recovery in people with acute ischemic stroke. It is for those whose symptoms have not improved or are getting worse after initial treatment.
This trial tests whether giving a clot-dissolving medication directly into the brain's blood vessels during a standard procedure (mechanical thrombectomy) can improve outcomes for people with a stroke caused by a blockage in a medium-sized artery. It may be an option for patients who arrive at the hospital within 24 hours of symptom onset and have enough salvageable brain tissue.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.